222 Users Online
Franz Cell and Vapometer Market Segmented By Jacketed Franz Cells, Unjacketed Franz Cells, Vapometer Devices, Franz Cell Adaptors Product in Pharmaceutical Companies, Academic & Research Institutes, CROs/CDMOs
Global revenue from the Franz cell and vapometer market was US$ 6,670.2 Th in 2021, with the worldwide market estimated to progress at a value CAGR of 3.4% to reach US$ 9,538.0 Th by the end of 2032.
According to Persistence Market Research, the Franz cells product type segment ended up with a market value of US$ 6,339.8 Th at the end of 2021.
| Attribute | Key Insights |
|---|---|
|
Franz Cell and Vapometer Market Size (2022) |
US$ 6,844.5 Th |
|
Projected Market Value (2032) |
US$ 9,538 Th |
|
Global Market Growth Rate (2022-2032) |
3.4% CAGR |
|
Market Share of Top 5 Countries |
56.9% |
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
The global market for Franz cells and vapometers recorded a historic CAGR of 1.8% over the last 9 years from 2012 to 2021.
Due to the advantages offered by the transdermal route of drug delivery, there has been an increase in the use of transdermal drugs. The usage of these transdermal drugs is directly proportional to the need for the development of transdermal drugs for various indications such as hypertension, bladder muscle dysfunction, menopausal symptoms, and others.
Subsequently, this increase in development surges the number of in-vitro permeation studies that are supported by Franz cells.
Since the transdermal route of administration is not invasive and acts as an aid in eliminating the exposure of first pass metabolism, there is an increase in the adoption of transdermal drug products. These can easily be self-administered when compared to intravenous injections. It is very convenient for patients to apply any type of transdermal drug products such as gels, emulsions, and transdermal patches.
Apart from this, the rise in regulatory approvals of transdermal drug products provides a positive aspect for the growth of the Franz cell and vapometer market. The approval of these transdermal drugs relies on drug formulations that are verified through the in-vitro testing of the skin absorption by using Franz diffusion cells.
There are numerous transdermal drugs and products that have been approved by regulatory bodies such as FDA.
The global Franz cell and vapometer market is expected to progress at a value CAGR of 3.4% and reach US$ 9,538 Th by 2032.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version“Rapidly Increasing Adoption of Transdermal Drug Products across Various Indications to Push Market Growth”
Transdermal drug products have seen increased usage for various health conditions such as osteoporosis, contraception, chronic pain, nausea, and vomiting caused due to chemotherapy, neurological disorders such as attention-deficit hyperactivity disorder, depressive disorders, and many others.
Franz cells and vapometers are extensively being used for the evaluation of the degree of efficiency of transdermal drugs.
When it comes to the cosmetics industry, the application of transdermal drugs is pretty high. It is easier for people to apply topical solutions on their skin wherever required on being advised to do so. It is very important to evaluate the active ingredients in these transdermal drugs, and that is where the role of Franz cells and vapometers comes into play.
These Franz cell systems are designed to imitate the behavior of actives and formulations when applied to the skin. This increase in demand represents the growth of the Franz cell and vapometer market.
At present, significant increase in the number of pharmaceutical companies is because of the rising global disease burden. Rise in the number of pharmaceutical companies points to the abundance of opportunities present for the development of novel transdermal drugs. The reason for this increase would be the advantages that are being offered by the transdermal route of administration.
“Skin Acts as Barrier in Development of Transdermal Drugs”
The physiology of the skin acts as a barrier to the optimized penetration and permeation of transdermal drugs. These barriers are characterized as mechanical barriers; for example, stratum corneum, tight junctions, etc. This stratum corneum constitutes dead keratinocytes and lipids, which form a molecular architecture that the drug molecules need to permeate to be effective. The barrier function of the skin is calculated using the transepidermal water loss measurement device, such as a vapometer.
Researchers focus on the development of such drugs can be successful. These strategies are none other than enhancement methods used for increasing the penetration and permeation capabilities of transdermal drug products. Enhancement methods include vesicles and particles, energy-driven methods, stratum corneum modification, and drug or vehicle interactions.
Since these barriers restrict the progress of the development of transdermal drugs, this may hamper market growth to some extent.
Sales Team
Client Partner
Why is the U.S. Franz Cell and Vapometer Market So Far Ahead?
“Rising Number of Approvals of Transdermal Drugs by FDA”
The U.S. accounted for 93.6% market share in the North America Franz cell and vapometer market in 2021.
Due to the advantageous nature of the transdermal route of administration, the adoption of transdermal drug products and transdermal drug delivery systems is quite high, which shows inflation in the number of transdermal drugs available in the market.
The presence of various manufacturers such as PremeGear Inc. and Logan Instruments Corp. and distributors such as MSP Corporation is quite high in the U.S. This has boosted the availability of products in the Franz cell and vapometer market.
How is China Emerging as a Prominent Market for Franz Cells and Vapometers?
“Increasing Adoption of Transdermal Drug Delivery in China”
China held the largest market share of 43.1% of the East Asia Franz cell and vapometer market in 2021.
As there are various advantages that the administration of transdermal drug delivery systems bring forward, such as minimal side effects, minimizing the frequency of dosing, and others, it is considered more adaptable than the intravenous and intramuscular route of administration.
The testing of these drugs is supported by Franz cells, which has a positive impact on the China Franz cell and vapometer market.
Why is the Drug Delivery Segment Expected to Drive High Market?
“Rising Number of Permeation and Penetration Studies”
The Franz cell (for transdermal drug delivery) segment held 95% share of the overall market in 2021.
Increasing interest in transdermal drug products is due to the beneficial characteristics of the transdermal route of administration. This has increased the number of permeation and penetration studies that are conducted to ensure whether transdermal drugs would be able to penetrate and permeate the skin with the right quantity.
The Franz cell is a key apparatus for permeation and penetration studies, thus holding a dominant market share.
Which End User Accounts for Higher Adoption of Franz Cells and Vapometers?
“Pharmaceutical Companies Lead the Way”
Pharmaceutical companies held a high share of 49% with a market value of US$ 3,266.2 Th in 2021.
It is pharmaceutical companies that fulfill the requirements of transdermal drugs. Increasing research and development of transdermal drugs is associated with researchers working in pharmaceutical companies.
Hence, demand for Franz cells is more from pharmaceutical companies when compared to other end users.
To strengthen their presence around the world, key players in the Franz cell and vapometer market are increasing their number of distributors. For example, Canadian Sales Center (Logan Instruments Corp.) in North America, Jover Scientech, S.L. in Europe, Diafana Representaciones in Latin America, Meganede CC in the Middle East and Africa, and many others in other regions.
Another significant approach noticed in the industry is the inclination toward providing top-class technical support and services to customers, as well as the adoption of a sustainable growth approach.
For instance:
| Attribute | Details |
|---|---|
|
Forecast Period |
2022-2032 |
|
Historical Data Available for |
2012-2021 |
|
Market Analysis |
USD Thousand for Value |
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
Franz Cell and Vapometer Market by Product:
Franz Cell and Vapometer Market by End User:
Franz Cell and Vapometer Market by Region:
The global Franz cell and vapometer market was valued at US$ 6,670.2 Th in 2021.
Revenue from Franz cells and vapometers is set to increase at 3.4% CAGR and reach US$ 9,538.0 Th by 2032.
Demand for Franz cells and vapometers increased at 1.8 % CAGR from 2012 to 2021.
The U.S., China, Germany, India, and U.K. account for most demand for Franz cell and vapometer products, currently holding 56.9% market share.
The U.S. accounted for 93.6% share of the North American market in 2021.
Henkel AG & Co. KGaA, Teledyne Instruments, Inc., and XENOMETRIX AG are the top three manufacturers of Franz cells and vapometers.
The Europe market is predicted to expand at 3.5% CAGR over the decade.
China held 43.1% market share in East Asia in 2021, while Japan accounted for 34.3% share.
The U.K. market held 19.8% share in the Europe Franz cell and vapometer market in 2021.
